FMED | IBB | FMED / IBB | |
Gain YTD | 5.666 | 1.612 | 351% |
Net Assets | 54.3M | 6.7B | 1% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 10.00 | 13.00 | 77% |
Yield | 0.00 | 0.30 | - |
Fund Existence | 5 years | 24 years | - |
FMED | IBB | |
---|---|---|
RSI ODDS (%) | 2 days ago56% | 2 days ago89% |
Stochastic ODDS (%) | 2 days ago82% | 2 days ago90% |
Momentum ODDS (%) | 2 days ago78% | 2 days ago88% |
MACD ODDS (%) | 2 days ago90% | 2 days ago82% |
TrendWeek ODDS (%) | 2 days ago78% | 2 days ago87% |
TrendMonth ODDS (%) | 2 days ago85% | 2 days ago88% |
Advances ODDS (%) | 15 days ago78% | 2 days ago87% |
Declines ODDS (%) | 6 days ago80% | 6 days ago85% |
BollingerBands ODDS (%) | 2 days ago71% | 2 days ago90% |
Aroon ODDS (%) | N/A | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IUEFX | 25.87 | -0.14 | -0.54% |
JPMorgan International Focus R5 | |||
FWOZX | 17.84 | -0.12 | -0.67% |
Fidelity Advisor Women's Leadership Z | |||
VGRTX | 79.69 | -0.57 | -0.71% |
JPMorgan US Value R2 | |||
FIDAX | 20.28 | -0.27 | -1.31% |
JHancock Financial Industries A | |||
RYAVX | 74.31 | -1.02 | -1.35% |
Rydex S&P MidCap 400 Pure Value H |
A.I.dvisor indicates that over the last year, FMED has been loosely correlated with NTLA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if FMED jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | -0.16% | ||
NTLA - FMED | 65% Loosely correlated | -1.87% | ||
TECH - FMED | 61% Loosely correlated | -1.17% | ||
TMO - FMED | 60% Loosely correlated | -0.27% | ||
TXG - FMED | 60% Loosely correlated | -1.80% | ||
PODD - FMED | 59% Loosely correlated | -0.81% | ||
More |